Labroots is excited to announce our 10th Annual Genetics Week Virtual Event Series held on April 19-21, 2022!
Genetics Week Virtual Event Series 2022 will offer a multi-day content-rich program combining stellar expertise from world-renowned keynote and featured speakers in the areas of Genetics & Genomics an expanding field of biology and human health, Molecular Diagnostics, exploring best laboratory practices and novel diagnostic applications, and Precision Medicine, spanning innovative technologies and solutions transforming healthcare and changing how patients are treated today.
Over the three days, invited lectures, thought-provoking discussions, and posters will be presented by academia and industry experts, professionals in medical and clinical genetics, scientific leaders, and research scholars.
The tracks will include:
Genetics and Genomics - Dive into Genetics & Genomics with tracks covering technological advancements, novel approaches, and demographic approaches to disease.
Advancements in Genomic Technologies
Sex, Epigenetics, Aging, and Disease
New Approaches in the Genetics of Disease
Precision Medicine - Optimize efficiency and patient care through molecular and genetic profiling. In this track you can follow important discourse on real-world clinical applications of precision medicine with new technologies and therapeutics.
Therapeutics in Precision Medicine
Precision Medicine in Clinical Practice
The Role of Technology in Precision Medicine
Molecular Diagnostics - Using genetics to facilitate detection, diagnosis, classification, and prognosis, this topic focuses on new technologies in testing and diagnosis.
Emerging Technologies and Methodologies in Molecular Diagnostics
Liquid Biopsies (Cancer Monitoring and Screening)
Infectious Disease Diagnostics - COVID-19 Testing
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster (with optional video summary) and discuss results with interested colleagues through email and our networking lounge. Plan now to have your poster included in the 2022 Genetics Virtual Week. Submit your abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global genetics community with a high degree of interaction through live-streaming video and chat sessions.
Continuing Education – Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 50 credits. This event will also provide CEU's for Genetic Counselors. 9 presentations have been approved by the NSGC to offer Category 1 CEU's.
Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.
Connect with us!
When you attend the event remember to use the hashtag #LRgenetics to follow the conversation and connect with other members of the global Genetics & Genomics community! Follow @Genetics_LR on Twitter and @GeneticsandGenomics on Facebook to connect with our specialist Genetics & Genomics Writers and stay up to date with the latest Trending News.
Global Product Manager NGS, QIAGEN
Global Product Manager, UNGS Genotyping
Senior Principal Scientist, QIAGEN Digital Insights
Global Market Development Manager, Molecular Biology, Thermo Fisher Scientific
R&D Scientist, Molecular Biology, Thermo Fisher Scientific
Research Associate II, Research & Development, Jumpcode Genomics
Deputy Head, Diagnostics Strategy and Development, Alexion Pharmaceuticals, Inc.
Product Manager for Sample Preparation at Miltenyi Biotec
Director, Reagent and Assay Development, Roche Sequencing Solutions
Professor of Oncology and Associate Director of Clinical Research, Albert Einstein College of Medicine, Montefiore Medical Center
Director Scientific & Technical Affairs, Thermo Fisher Scientific
Director, ManTRa Diagnostics Ltd, Research Associate, Department of Translational Radiobiology, University of Manchester
Co-Founder and Chief Science Officer, Genomenon
President and CEO, Rady Children's Institute for Genomic Medicine
Senior Product Manager, Thermo Fisher Scientific
Instructor, Harvard T.H. Chan School of Public Health, Fellow, Channing Division of Network Medicine, Brigham & Women's Hospital
Vice President of Physician and Patient Strategies, Inozyme Pharma
Professor of Computational Biology and Bioinformatics, Chair of the Department of Biostatistics, Harvard University, Dana-Farber Cancer Institute
FQR-S/MSSS/CHUQ Research Awardee in Health Technology Assessment and Evidence Based Laboratory Medicine, Professor, Department of Molecular Biology, Medical Biochemistry and Pathology at the Faculty of Medicine, Université Laval, Researcher, Centre de recherche du CHU de Québec
Product Manager for Flow Sorting at Miltenyi Biotec
R&D Manager for Molecular and Synthetic Biology, Thermo Fisher Scientific
Vice Chair of Pathology for Translational Research, Professor of Pathology, University Hospitals Cleveland Medical Center/Seidman Cancer Center, Case Western Reserve University/Case Comprehensive Cancer Center
Jumpcode Genomics is improving the understanding of human biology by uncovering genomic mysteries. We are empowering scientists to advance the field of genomic research and discover unbiased data insights by increasing sensitivity and access to new sample types and broad ...See more See less
As the scientific community races to solve this evolving global health crisis, Twist Bioscience is proud to carry on as an active partner for all of your research needs. Twist's unique silicon-based DNA writing platform allows for the rapid development of NGS panels for viral ...See more See less
For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell ...See more See less
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving ...See more See less
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological ...See more See less
Roche Sequencing Solutions (RSS) is building on Roche's legacy of innovation to transform next-generation sequencing and its application. By simplifying workflows and expanding assay menus, we are broadening access to genomic data and lowering barriers to routine use.
This event will also provide CEU's for Genetic Counselors. 9 presentations have been approved by the NSGC to offer Category 1 CEU's. Please fill out the evaluation for each presentation you attended and submit the form(s) to email@example.com.
Suzie Alarcon CGMBS, MB(ASCP)CM is the manager of the Next Generation Sequencing Core at the La Jolla Institute for Immunology (LJI) and Team Leader of Team LJI - winner of the XPRIZE Rapid COVID Testing competition. Suzie has 18 years of experience working in molecular biology ...See more See less
Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...See more See less
Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...See more See less
Louisa Ive, MSc HCPC, received her undergraduate education at University College London, London and completed her Clinical Scientist training at St George's University Hospital, London. She is a practicing Clinical Scientist, certified by the Health & Care Professions Council and ...See more See less
Eugean Jiwanmall's past professional experiences include basic science and clinical research. In his current role as a Senior Research Analyst for Medical Policy & Technology Evaluation at Independence Blue Cross' Claim Payment Policy Department within Facilitated Health ...See more See less
Dr. Mark Kiel is Co-Founder and Chief Science Officer at Genomenon, where he oversees the company's scientific direction and product development. After spending 15 years preparing for a life of academic research, Mark became convinced that revolutionary change in genomics was ...See more See less
Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...See more See less
Degree: Ph.D. in Biochemistry, Institute of Bioorganic Chemistry, Polish Academy of Science, Poznań, Poland. Postdoc fellow in Human Genome Sequencing Center, Baylor College of Medicine... Interests: I'm interested in studying genomic variants and their effect, including the ...See more See less
Tatjana is an immunologist with more than two decades of experience working at biotech and pharma companies from start-ups to large global corporations ( Pfizer,Inc. being the latest), contributing significantly to team efforts and successes of more than thirty early and clinical ...See more See less
Dorottya earned her MD and PhD in clinical medicine from Semmelweis University of Medicine in Hungary. Holding postdoctoral fellowships at Baylor College of Medicine/Texas Children's Hospital and Columbia University, she has 10+ years of experience in translational medicine ...See more See less
John Quackenbush is Professor of Computational Biology and Bioinformatics and Chair of the Department of Biostatistics at the Harvard TH Chan School of Public Health and Professor at the Dana-Farber Cancer Institute. John's PhD was in Theoretical Physics but a fellowship to work ...See more See less
Dr. Fritz Sedlazeck completed his PhD in 2012 in the group of Dr. Arndt von Haeseler at the Max F. Perutz Laboratory in Vienna. After a two year postdoc, he transitioned to the lab of Dr. Michael Schatz at Cold Spring Harbor Laboratory and later to Johns Hopkins University. Since ...See more See less
Dr. Tao Wu received his B.S. from Nankai University a leading academic institution in China. In his last year at college, his reading of "What Is Life? The Physical Aspect of the Living Cell" (by physicist Erwin Schrödinger, 1944) inspired him to pursue a career in deciphering ...See more See less